Fourth and final issue of GaBI Journal’s seventh volume
Nomenclature for biosimilars; a continuing thorny issue
Ongoing activities to influence the prescribing of proton pump inhibitors within the Scottish National Health Service: their effect and implications
The need for distinct nomenclature for originator and biosimilar products
First GCC stakeholder meeting on approval process, interchangeability/substitution and safety of biosimilars 2017 – Report
US generic prescription drug markets 2004‒2016
Source URL: http://gabi-journal.net/2018-4-gabi-journal-table-of-contents.html
Copyright ©2019 GaBI Journal unless otherwise noted.